164 related articles for article (PubMed ID: 35762283)
1. TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages.
Li D; Zhang J; Yuan S; Wang C; Chang J; Tong Y; Liu R; Sang T; Li L; Li J; Ouyang Q; Chen X
Cell Prolif; 2022 Oct; 55(10):e13299. PubMed ID: 35762283
[TBL] [Abstract][Full Text] [Related]
2. Remote Ischemic Preconditioning Ameliorates Renal Fibrosis After Ischemia-Reperfusion Injury via Transforming Growth Factor beta1 (TGF-β1) Signalling Pathway in Rats.
Zhou C; Liu J; Ge Y; Zhu Y; Zhou L; Xu L; Xu Z; Wu R; Jia R
Med Sci Monit; 2020 Feb; 26():e919185. PubMed ID: 32024811
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-specific deletion of transforming growth factor-β1 does not prevent renal fibrosis after severe ischemia-reperfusion or obstructive injury.
Huen SC; Moeckel GW; Cantley LG
Am J Physiol Renal Physiol; 2013 Aug; 305(4):F477-84. PubMed ID: 23761668
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.
Jiang S; Tang Q; Rong R; Tang L; Xu M; Lu J; Jia Y; Ooi Y; Hou J; Guo J; Yang B; Zhu T
Eur J Pharmacol; 2012 Aug; 688(1-3):56-61. PubMed ID: 22609232
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic effects of KS370G, a caffeamide derivative, in renal ischemia-reperfusion injured mice and renal tubular epithelial cells.
Chuang ST; Kuo YH; Su MJ
Sci Rep; 2014 Jul; 4():5814. PubMed ID: 25056456
[TBL] [Abstract][Full Text] [Related]
6. Gremlin1 and TGF-β1 protect kidney tubular epithelial cells from ischemia-reperfusion injury through different pathways.
Gao X; Han L; Yao X; Ma L
Int Urol Nephrol; 2022 Jun; 54(6):1311-1321. PubMed ID: 34633599
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
Si X; Liu X; Li J; Wu X
Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
10. P144, A TGF-β1 antagonist peptide, synergizes with sildenafil and enhances erectile response via amelioration of cavernosal fibrosis in diabetic rats.
Li WJ; Wang H; Zhou J; Li B; Zhang J; Lu M; Wang Z
J Sex Med; 2013 Dec; 10(12):2942-51. PubMed ID: 24134744
[TBL] [Abstract][Full Text] [Related]
11. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1 inhibitor P144 protects against benign restenosis after esophageal stenting through TGF-β1/Smads signaling pathway inhibition.
Wu JZ; Zhou C; Liu S; Zhang JX; Yang W; Shi HB; Zhou WZ
Arab J Gastroenterol; 2024 May; 25(2):214-222. PubMed ID: 38369402
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Aggravates Post-ischaemic Renal Fibrosis through Persistent Activation of TGF-β
Kim DJ; Kang JM; Park SH; Kwon HK; Song SJ; Moon H; Kim SM; Seo JW; Lee YH; Kim YG; Moon JY; Lee SY; Son Y; Lee SH
Sci Rep; 2017 Dec; 7(1):16782. PubMed ID: 29196746
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway.
Ying H; Fang M; Hang QQ; Chen Y; Qian X; Chen M
J Cell Mol Med; 2021 Sep; 25(18):8662-8675. PubMed ID: 34327818
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury.
Cai J; Jiao X; Zhao S; Liang Y; Ning Y; Shi Y; Fang Y; Ding X; Yu X
Cytotherapy; 2019 May; 21(5):535-545. PubMed ID: 30685215
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-19 restores vascular endothelial cell function in lower limb ischemia-reperfusion injury through the KLF10-dependent TGF-β1/Smad signaling pathway in rats.
Xu YL; Zhang MH; Guo W; Xue Y; Du X; Zhang T; Wu N; Wu Y
J Cell Biochem; 2018 Nov; 119(11):9303-9315. PubMed ID: 29953651
[TBL] [Abstract][Full Text] [Related]
17. STAT1 regulates macrophage number and phenotype and prevents renal fibrosis after ischemia-reperfusion injury.
Kemmner S; Bachmann Q; Steiger S; Lorenz G; Honarpisheh M; Foresto-Neto O; Wang S; Carbajo-Lozoya J; Alt V; Schulte C; Chmielewski S; Bluyssen HAR; Heemann U; Baumann M; Lech M; Schmaderer C
Am J Physiol Renal Physiol; 2019 Feb; 316(2):F277-F291. PubMed ID: 30403164
[TBL] [Abstract][Full Text] [Related]
18. P144 a Transforming Growth Factor Beta Inhibitor Peptide, Generates Antifibrogenic Effects in a Radiotherapy Induced Fibrosis Model.
Cruz-Morande S; Dotor J; San-Julian M
Curr Oncol; 2022 Apr; 29(4):2650-2661. PubMed ID: 35448191
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-catenin signaling pathway contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury and is possibly related to the transforming growth factorβ1/Smad3 signaling pathway.
Zhang G; Ge M; Han Z; Wang S; Yin J; Peng L; Xu F; Zhang Q; Dai Z; Xie L; Li Y; Si J; Ma K
Biomed Pharmacother; 2019 Feb; 110():420-430. PubMed ID: 30530044
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway.
Wang S; Yin J; Ge M; Dai Z; Li Y; Si J; Ma K; Li L; Yao S
Biomed Pharmacother; 2016 Mar; 78():280-290. PubMed ID: 26898453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
